Key facts
- It has raised $43.6M; the latest was Later Stage VC in Sep 2024.
- Notable investors include First Trust Capital Partners, Athyrium Capital Management, Cisco Big Awards, DNV Ventures, Imperial Create Lab — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for uMotif
- ·The full record, as it builds
Funding rounds
No funding rounds for uMotif are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About uMotif
Developer of an e-clinical platform designed to measure patients' health, outcomes, and experience. The company's platform provides patient-facing technology to capture data for clinical research initiatives and capture compliant, validated patient-generated e-consent, eCOA / ePRO, PROM, and PREM data, enabling clinical to put patients at the center of clinical research.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2012
- Employees
- 94
- Website
- umotif.com/
- Ownership
- Privately Held (backing)
uMotif doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in uMotif shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on uMotif in its N-PORT filings yet. We sweep new filings monthly.